Zweig Di Menna Associates LLC Arvinas, Inc. Transaction History

Zweig Di Menna Associates LLC

  • $1.25 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
SELL
$60.45 - $84.26 $4.42 Million - $6.17 Million
-73,190 Closed
0 $0
Q1 2021

Apr 26, 2021
BUY
$58.19 - $91.37 $1.12 Million - $1.76 Million
19,300 Added 35.81%
73,190 $4.84 Million
Q4 2020

Jan 26, 2021
BUY
$20.19 - $84.93 $1.09 Million - $4.58 Million
53,890 New
53,890 $4.58 Million

Others Institutions Holding ARVN

# of Institutions
227
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $937M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email